Quarterly Result14 Feb 2026, 09:34 pm
Brawn Biotech Ltd. Announces Q3 and Year-to-Date Financial Results for 2025
AI Summary
Brawn Biotech Ltd. announced its unaudited financial results for the quarter and year-to-date ended 31st December 2025. The Board of Directors approved the results in a meeting held on 14th February 2026. The company reported a net profit from ordinary activities after tax for the quarter at Rs. 1,205 Lakhs and Rs. 12,813 Lakhs for the nine-month period. The earnings per share (after extraordinary items) for the quarter is Rs. 1.50.
Key Highlights
- Brawn Biotech Ltd. reported a net profit from ordinary activities after tax of Rs. 1,205 Lakhs for Q3 2025.
- The net profit from ordinary activities after tax for the nine-month period ended 31st December 2025 is Rs. 12,813 Lakhs.
- The earnings per share (after extraordinary items) for the quarter is Rs. 1.50.
- The financial results have been reviewed by the Audit Committee and approved by the Board of Directors.
- The company is primarily engaged in the business of Pharmaceuticals.
Price Impact
More from BRAWN